CDK7 is an essential gene in both ER-wild-type and ER-mutant breast cancer, and ER-mutant MCF7 cells, that are partially resistant to anti-oestrogens, are sensitive to CDK7 inhibition [125, 138]. This evidence concerns the gene CDK7 and breast carcinoma.